Protara Therapeutics (TARA) Earnings Date & Reports

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TARA is expected to report earnings to rise 9.23% to -33 cents per share on July 30

Protara Therapeutics TARA Stock Earnings Reports

Q2'26

Est.

$-0.34

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.07

Q2'25

Beat

by $0.05

The last earnings report on May 13 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 176.79K shares outstanding, the current market capitalization sits at 230.72M.

View a ticker or compare two or three

Compare

TARA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TARA